Access Bio, INC.
At a glance
Employees20-99
In business sinceNot reported
HeadquartersMonroe Township, NJ
SAM.gov UEIEZEJBJ28AMV4
Access Bio develops in vitro diagnostic products including COVID-19 detection kits, rapid diagnostic tests for conditions such as malaria, dengue, flu, HIV, and syphilis, analyzers, and molecular diagnostic tests for viral and infectious diseases. The company serves international public health agencies and organizations globally.
Summarized from the company’s own website
What they make
Coronavirus Antigen Detection Test System.Dengue Serological ReagentsGlucose-6-Phosphate Dehydrogenase (Erythrocytic), ScreeningMulti-Analyte Controls, All Kinds (Assayed)Multi-Analyte Respiratory Virus Antigen Detection TestOver-The-Counter Covid-19 Antigen TestPlasmodium Spp. Detection ReagentsReagent, Coronavirus SerologicalReagents, 2019-Novel Coronavirus Nucleic AcidReagents, Non-Variola Orthopoxvirus Or Monkeypox Virus Singleplex Antigen Tests
Their plants
2 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Access Bio, INC. | Monroe Township | NJ | 20–99 | ACTIVE |
| Access Bio, INC. | Somerset | NJ | — | UNVERIFIED |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.